Effective serological and molecular screening of deceased tissue donors.
A comprehensive and effective screening programme is essential to support the banking of tissues from deceased donors. However, the overall quality of the samples obtained from deceased donors, quantity and condition, is often not ideal, and this may lead to problems in achieving accurate and reliable results. Additionally a significant percentage of referrals are still rejected upon receipt as unsuitable for screening. We are actively involved in improving the overall quality of deceased donor screening outcomes, and have specifically evaluated and validated both serological and molecular assays for this purpose, as well as developing a specific screening strategy to minimise the specificity issues associated with serological screening. Here we review the nature and effectiveness of the deceased donor screening programme implemented by National Health Service Blood and Transplant (NHSBT), the organisation with overall responsibility for the supply of tissue products within England. Deceased donor screening data, serological and molecular, from August 2007 until May 2012 have been collated and analysed. Of 10,225 samples referred for serology screening, 5.5 % were reported as reactive; of 2,862 samples referred for molecular screening, 0.1 % were reported as reactive/inhibitory. Overall 20 % of the serological and 100 % of the molecular screen reactivity was confirmed as reflecting true infection. The use of a sequential serology screening algorithm has resulted in a marked reduction of tissues lost unnecessarily due to non-specific screen reactivity. The approach taken by NHSBT has resulted in the development of an effective and specific approach to the screening of deceased tissue donors.
National Transfusion Microbiology Reference Laboratory, NHS Blood and Transplant, Charcot Road, Colindale Avenue, London, NW9 5BG, UK, alan.kitchen@nhsbt.nhs.uk.
A D
AD
Kitchen
J A
JA
Newham
H L
HL
Gillan
D046148:Donor Selection / Q000379:methods*; D006801:Humans; D057089:Pathology, Molecular / Q000379:methods*; D015203:Reproducibility of Results; D012699:Serology / Q000379:methods*; D014019:Tissue Donors